![]() |
Volumn 20, Issue 4, 2015, Pages 127-
|
In women with gestational diabetes requiring drug treatment, glibenclamide may be inferior to insulin and metformin: Metformin (plus insulin when required) performs better than insulin
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GLIBENCLAMIDE;
GLYCOSYLATED HEMOGLOBIN;
INSULIN;
METFORMIN;
ANTIDIABETIC AGENT;
BIRTH WEIGHT;
CESAREAN SECTION;
DRUG TREATMENT FAILURE;
FETUS OUTCOME;
GESTATIONAL AGE;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
HYPOGLYCEMIA;
INSULIN TREATMENT;
LARGE FOR GESTATIONAL AGE;
MACROSOMIA;
META ANALYSIS;
NOTE;
PERINATAL MORTALITY;
PREECLAMPSIA;
PREGNANCY DIABETES MELLITUS;
PREMATURE LABOR;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SMALL FOR DATE INFANT;
SYSTEMATIC REVIEW;
WEIGHT GAIN;
DIABETES, GESTATIONAL;
FEMALE;
PREGNANCY;
DIABETES, GESTATIONAL;
FEMALE;
GLYBURIDE;
HUMANS;
HYPOGLYCEMIC AGENTS;
INSULIN;
METFORMIN;
PREGNANCY;
|
EID: 84938936889
PISSN: 13565524
EISSN: 14736810
Source Type: Journal
DOI: 10.1136/ebmed-2015-110186 Document Type: Note |
Times cited : (2)
|
References (4)
|